Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
GlaxoSmithKline (GSK) said it was 'disappointed' after having to call an end to its clinical trial for its treatment for non-small cell lung cancer (NSCLC). The MAGRIT trial, a phase three trial of its MAGE-A3 antigen-specific cancer immunotherapeutic in NSCLC patients, has been ended as GSK couldn
Read more
LONDON (Alliance News) - Shares have opened flat to slightly down Wednesday, despite a record close in the US and strong UK house price data.
Goldman Sachs has added Go-Ahead Group to its Conviction Buy List with a price target of 2,310 pence. The bus and train comp
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had chosen to stop the Phase III trial of its MAGE-A3 cancer immunotherapeutic in non-small cell lung cancer patients, as it said it would not be possible to identify a sub-population of MAGE-A3 positive patients with a specific gene
Read more
LONDON, April 2 (Reuters) - GlaxoSmithKline has stopped a high-profile clinical trial using a novel vaccine to fight lung cancer after deciding it will not be possible to find a sub-group of patients who might benefit. The decision comes less than two weeks after the British drugmaker said
Read moreLONDON, April 1(Reuters) - GlaxoSmithKline's AIDS drugs business is to add one of its latest HIV medicines to a patent pool - cutting its future price for developing countries and pooling intellectual property rights. ViiV Healthcare, which is majority owned by the British drugmaker, said t
Read moreLONDON, April 1(Reuters) - GlaxoSmithKline's AIDS drugs business is to add one of its latest HIV medicines to a patent pool - cutting its future price for developing countries and pooling intellectual property rights. ViiV Healthcare, which is majority owned by the British drugmaker, said t
Read moreApril 1 (Reuters) - The U.S. Food and Drug Administration on Tuesday defended its proposal to require generic drugmakers to update the prescribing information on their products if they become aware of new safety information, a move the industry says will open them to product liability lawsuits an
Read more(Adds company statement) By Vrinda Manocha April 1 (Reuters) - The U.S. Food and Drug Administration found that a drug ingredient manufactured at a GlaxoSmithKline Plc plant in Ireland was contaminated and said the company did not take sufficient action to resolve the problems.
Read more(Corrects last paragraph to say that one Sun Pharma plant and some Wockhardt plants have been barred from exporting drugs to the US. The incorrect version suggested that all Sun Pharma and Wockhardt plants were barred) April 1 (Reuters) - The U.S. Food and Drug Administration found contamin
Read moreApril 1 (Reuters) - The U.S. Food and Drug Administration found contamination of drug ingredients manufactured at a GlaxoSmithKline Plc plant in Ireland and said the company did not take sufficient action to resolve the problems. The news comes just days after GSK said it was recalling all
Read moreLONDON (Alliance News) - Weir Group's takeover approach to Finnish rival Metso is the biggest of a flurry of deals and potential deals announced Tuesday, with GKN acquiring the William's Formula 1 team parent's hybrid engine unit and Capita bo
Read moreLONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday a Phase III study of patients with advanced renal cell carcinoma showed that 70% of patients preferred Glaxo's Votrient treatment to Sutent, which is owned by CP Pharmaceuticals International C.V. CP Pharmaceuticals is comprised of
Read more- ECB under pressure to move on rates - Stocks erase gains but near three-week highs - Copper futures lower ahead of manufacturing PMIs - Small Russian troop pull back techMARK 2,764.65 +0.09% FTSE 100 6,598.37 -0.26% FTSE 250 16,273.72 +0.57% UK stocks ended the day slightly lower as investors op
Read moreBabcock International Group was the top riser on Monday after confirming the UK government has chosen the engineering company to manage the decommissioning of 12 nuclear sites. Rio Tinto and Anglo American gained after Credit Suisse named the companies as its top picks in the metals and mining sec
Read more* Up to 100 mln pounds for new drug manufacturing in Africa * GSK looks at Rwanda, Ghana and Ethiopia for new factories * Further investment in drug R&D focused on continent (Adds CEO interview) By Ben Hirschler March 31 (Reuters) - Drugmaker GlaxoSmithKline plans to inv
Read more
Last checked at